Version May 2024
| Hereditary thrombophilias |
| Factor V Leiden |
| Prothrombin G20210A |
| Protein S deficiency |
| Protein C deficiency |
| Antithrombin deficiency |
| Other disorders and risk factors |
| Antiphospholipid syndrome (APS) |
| Central venous catheter |
| Certain cancer therapies (eg, tamoxifen, thalidomide, lenalidomide, asparaginase) |
| Congenital heart disease |
| Heart failure |
| Hormone replacement therapy |
| Immobilization/immobility |
| Inflammatory bowel disease |
| Malignancy |
| Myeloproliferative neoplasms |
| Essential thrombocythemia |
| Polycythemia vera |
| Nephrotic syndrome |
| Obesity |
| Older age (≥65 years) |
| Oral contraceptives |
| Paroxysmal nocturnal hemoglobinuria |
| Pregnancy, especially the first 6 weeks postpartum |
| Severe liver disease |
| Surgery, especially orthopedic |
| Trauma |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
